Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · technology

Closed Pfizer biopharma facility in Everett gets a new lease on life

14 August 2026 · By · Wire by Fusion42

Published

14 August 2026

Topic

technology

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at geekwire.com →

◆ Verified

Fusion42 · 14 August 2026 · Fusion42 review

Breakthrough Properties acquired the 270,000-square-foot biomanufacturing facility in Everett previously owned by Pfizer and leased it for 21 years to an unnamed global biopharmaceutical company, signaling renewed life for this suppressed asset amid growing domestic pharma manufacturing investments.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

Pharma manufacturing facilities shut by big companies are now available for lease and renewal. You in biopharma manufacturing can access facilities that expand capacity without building new sites.

◆ Coverage

1 source · 14 Aug 2026

◆ Related on Wire

◆ Topics

Biotechbiomanufacturingpharmareal-estateinvestmentus-market